SubHero Banner
Text

Lexette® (halobetasol propionate) – Expanded indication

August 18, 2021 - The FDA approved Mayne Pharma’s Lexette (halobetasol propionate), for the topical treatment of plaque psoriasis in patients 12 years of age and older.

Download PDF